Munich Reinsurance Co Stock Corp in Munich Purchases 83,894 Shares of Elevance Health, Inc. $ELV

Munich Reinsurance Co Stock Corp in Munich increased its position in shares of Elevance Health, Inc. (NYSE:ELV) by 44.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 274,158 shares of the company’s stock after purchasing an additional 83,894 shares during the period. Elevance Health makes up about 2.0% of Munich Reinsurance Co Stock Corp in Munich’s portfolio, making the stock its 13th biggest holding. Munich Reinsurance Co Stock Corp in Munich’s holdings in Elevance Health were worth $80,260,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Cvfg LLC lifted its holdings in shares of Elevance Health by 4.8% during the first quarter. Cvfg LLC now owns 1,612 shares of the company’s stock worth $472,000 after buying an additional 74 shares in the last quarter. Unison Advisors LLC grew its stake in shares of Elevance Health by 0.4% in the first quarter. Unison Advisors LLC now owns 7,430 shares of the company’s stock valued at $2,175,000 after acquiring an additional 32 shares in the last quarter. Greatmark Investment Partners Inc. increased its position in Elevance Health by 5.0% during the first quarter. Greatmark Investment Partners Inc. now owns 38,622 shares of the company’s stock worth $11,306,000 after acquiring an additional 1,845 shares during the period. Stephens Inc. AR increased its position in Elevance Health by 3.6% during the first quarter. Stephens Inc. AR now owns 9,498 shares of the company’s stock worth $2,781,000 after acquiring an additional 326 shares during the period. Finally, AdvisorShares Investments LLC raised its stake in Elevance Health by 14.3% in the 1st quarter. AdvisorShares Investments LLC now owns 1,600 shares of the company’s stock worth $468,000 after purchasing an additional 200 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors.

Insider Transactions at Elevance Health

In other Elevance Health news, Director Robert L. Dixon, Jr. sold 151 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $401.77, for a total transaction of $60,667.27. Following the completion of the transaction, the director directly owned 10,734 shares in the company, valued at $4,312,599.18. The trade was a 1.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.34% of the stock is owned by company insiders.

Elevance Health Trading Down 0.7%

ELV opened at $415.99 on Thursday. The stock has a market capitalization of $90.34 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 2.38 and a beta of 0.67. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $427.19. The company has a 50-day simple moving average of $395.21 and a 200 day simple moving average of $352.48.

Elevance Health (NYSE:ELV) last released its earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating the consensus estimate of $10.74 by $1.84. The firm had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the firm earned $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Analysts predict that Elevance Health, Inc. will post 26.86 EPS for the current fiscal year.

Elevance Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Wednesday, June 10th were paid a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is 29.26%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on ELV shares. Robert W. Baird boosted their price objective on shares of Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a report on Thursday, April 23rd. The Goldman Sachs Group raised their target price on shares of Elevance Health from $350.00 to $370.00 and gave the stock a “neutral” rating in a report on Friday, April 24th. UBS Group lifted their price target on shares of Elevance Health from $400.00 to $460.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Leerink Partners set a $364.00 price target on Elevance Health in a research note on Thursday, April 23rd. Finally, Guggenheim increased their price target on Elevance Health from $396.00 to $399.00 and gave the stock a “buy” rating in a research report on Friday, April 24th. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and an average price target of $422.10.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.